Capecitabine Manufacturer and Supply in China | CAS 154361-50-9

Beijing Southoncology International Hospital is proud to introduce a new product to our lineup, Capecitabine. As a trusted supplier of innovative oncology treatments in China, we are excited to offer this medication to our patients. Capecitabine, with CAS 154361-50-9, is an oral chemotherapy drug designed to treat certain types of breast, colorectal, and gastric cancers. This product is a valuable addition to our comprehensive range of cancer therapeutics, providing patients with another option in their fight against this devastating disease. Our commitment to providing high-quality, effective treatments is exemplified by our partnership with leading pharmaceutical companies to bring cutting-edge medications like Capecitabine to the market. Trust Beijing Southoncology International Hospital to deliver superior care and top-notch products to our patients.

Featured Products

  • Introducing our revolutionary cancer treatment drug, Capecitabine, with the CAS number 154361-50-9. This oral chemotherapy medication has been proven to effectively treat various forms of cancer, including breast, colon, and rectal cancer. With its targeted approach, Capecitabine inhibits the growth of cancer cells while minimizing damage to healthy cells, resulting in fewer side effects for patients. Our Capecitabine medication, with the CAS number 154361-50-9, comes in the form of tablets for convenient and easy administration. It is designed to be taken at home, allowing patients to maintain their daily routines while undergoing treatment. The ease of use and minimal disruption to daily life make Capecitabine a preferred choice for many cancer patients and healthcare professionals. Backed by extensive research and clinical trials, Capecitabine with the CAS number 154361-50-9 has been proven to be a safe and effective treatment option for cancer patients. Its innovative mechanism of action and reliable efficacy make it a valuable addition to cancer treatment regimens. As we continue to prioritize the development of advanced cancer treatments, our Capecitabine medication stands as a testament to our commitment to improving the lives of those affected by cancer. With its well-documented benefits and proven results, Capecitabine with the CAS number 154361-50-9 is a promising solution for cancer patients seeking effective and manageable treatment options.

  • A comprehensive guide to diagnosing hepatocellular carcinoma using ultrasound

    Beijing South Region Oncology Hospital has been at the forefront of cancer diagnosis and treatment for the past ten years. With a focus on integrating medical resources from all departments and promot

  • Experts are Warning about the Rapid Growth of Proliferation

    Beijing South Region Oncology Hospital Leads the Way in Proliferation Treatment For the past ten years, Beijing South Region Oncology Hospital has been at the forefront of diagnosing and treating var

  • Understanding Sarcoma Lung Cancer: Symptoms, Diagnosis, and Treatment Options

    Beijing South Region Oncology Hospital, a leading institution in the field of cancer treatment, has been at the forefront of diagnosing and treating various types of tumors for the past ten years. The

  • Understanding Neuroendocrine Tumor of the Liver: Causes, Symptoms, and Treatment Options

    Beijing South Region Oncology Hospital, a leading institution in the diagnosis and treatment of various tumors, has been making significant strides in the field of medical research. With a focus on ad
    • ;
Lung Cancer End Of Life, Lung Staging, Msi High Colon Cancer, Small Cell Lung Cancer Staging, Precision Therapy, Squamous Lung Cancer, Pulmonary Mass, Rectal Adenocarcinoma, Liver Cancer Hereditary, Small Lung Cancer,